Stock IMNN IMUNON, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Imunon, Inc.

Equities

IMNN

US15117N6022

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-04-22 pm EDT 		5-day change 1st Jan Change
1.27 USD +8.55% Intraday chart for Imunon, Inc. -13.61% +86.76%
Apr. 18 Imunon Receives FDA Approval to Start Phase 1 Trial of COVID-19 Booster Vaccine MT
Apr. 18 Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine DJ

Chart calendar Imunon, Inc.

c689b16cb77e4668bbfdccf3.93Gqpk-q9rf5g3Df6I-c4Mmq8Pccg0B_zjAFL6arTFU.lCPnygbjk4KrzgqYr_fEt7mcpaZE6DQz4wRHX8qfAgTaGc7XBO-_3oruBw~e5097ae04bf086c78e492e63d7274001

Upcoming events on Imunon, Inc.

2024-05-14 Q1 2024 Earnings Release (Projected)
2024-08-13 Q2 2024 Earnings Release (Projected)
2024-11-10 Q3 2024 Earnings Release (Projected)
2025-03-26 Q4 2024 Earnings Release (Projected)

Past events on Imunon, Inc.

2024-03-28 10:00 am Q4 2023 Earnings Call
2024-03-28 08:00 am Q4 2023 Earnings Release
2023-11-14 10:00 am Q3 2023 Earnings Call
2023-11-14 08:00 am Q3 2023 Earnings Release
2023-10-23 02:00 pm Edition of International Vaccines Congress
2023-09-14 04:00 pm R&D Day
2023-09-11 07:00 am H.C. Wainwright Global Investment Conference
2023-08-10 11:00 am Q2 2023 Earnings Call
2023-08-10 08:00 am Q2 2023 Earnings Release
2023-06-14 10:00 am Annual General Meeting
2023-06-12 Mass General Brigham World Medical Innovation Forum
2023-05-20 Viruses and Cells Gordon Research Conference
2023-05-11 11:00 am Q1 2023 Earnings Call
2023-05-11 08:00 am Q1 2023 Earnings Release
2023-04-18 09:00 am American Association for Cancer Research Meeting - Abstract No. 4440
2023-03-30 11:00 am Q4 2022 Earnings Call
2023-03-30 08:00 am Q4 2022 Earnings Release
2023-03-20 Vaccine Technology Summit
2022-11-29 A.G.P.’s Virtual Biotech Conference
2022-11-14 11:00 am Q3 2022 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,50
0,51
-0.99%		0,50
0,50
0%		0,50
0,50
0%		0,50
0,50
0%		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-20,6
-21,3
3.29%		-18,5
-18,1
-2.32%		-21,0
-21,1
0.4%		-24,9
-24,4
-1.98%		-21,0
-20,7
-1.62%
-22,7

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-18,7
-20,6
9.5%		-23,3
-23,3
-0.08%		-22,2
-22,2
0.14%		-37,5
-28,9
-29.6%		-20,8
-20,2
-3.17%
-23,0

Net income
Million USD		Released
Forecast
Spread 		-16,9
-19,6
13.92%		-21,5
-23,3
7.83%		-20,8
-22,2
6.38%		-35,9
-28,6
-25.48%		-19,5
-20,2
3.18%
-23,0

EPS
USD		Released
Forecast
Spread 		-11,5
-14,0
17.65%		-10,0
-10,9
8.22%		-3,83
-4,05
5.43%		-5,03
-4,19
-20.19%		-2,16
-2,23
3.28%
-2,27

Announcement Date25/03/2019/03/2131/03/2230/03/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,13
0,11
11.11%		0,13
0,11
15.39%		0,13
0,11
15.39%		0,13
0,11
11.11%		0,13
0,11
11.11%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-5,49
-5,58
1.67%		-5,84
-5,69
-2.66%		-5,98
-5,95
-0.53%		-6,17
-6,03
-2.47%		-6,93
-6,44
-7.55%		-5,68
-6,30
9.78%		-5,47
-6,27
12.73%		-3,90
-6,05
35.51%		-5,97
-5,61
-6.42%
-5,36


-5,60


-5,60


-5,96

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-5,61
-5,58
-0.4%		-10,5
-5,85
-79.09%		-6,04
-5,92
-2.08%		-6,15
-6,00
-2.47%		-14,8
-6,29
-135.12%		-5,59
-6,30
11.25%		-5,56
-6,28
11.47%		-3,48
-6,13
43.25%		-6,17
-5,55
-11.18%
-5,43


-5,77


-5,63


-6,10

Net income
Million USD		Released
Forecast
Spread 		-4,22
-5,58
24.39%		-10,5
-5,85
-79.09%		-6,04
-5,92
-2.08%		-6,15
-6,00
-2.47%		-13,2
-6,48
-104.24%		-5,59
-6,30
11.25%		-5,56
-6,28
11.47%		-3,48
-6,13
43.25%		-4,89
-5,55
11.9%
-5,43


-5,77


-5,63


-6,10

EPS
USD		Released
Forecast
Spread 		-3,62
-0,90
-302.22%		-1,82
-1,01
-81.09%		-0,87
-0,98
11.22%		-0,87
-0,81
-7.41%		-1,61
-0,84
-92.24%		-0,68
-0,69
1.45%		-0,61
-0,73
16.82%		-0,37
-0,66
43.94%		-0,52
-0,59
11.36%
-0,57


-0,60


-0,59


-0,51

Announcement Date31/03/2216/05/2215/08/2214/11/2230/03/2311/05/2310/08/2314/11/2328/03/24----

Upcoming sector events for Imunon, Inc.

Today 07:30 am KINIKSA PHARMACEUTICALS, LTD.: Q1 2024 Earnings Release
2024-04-23 INVENTISBIO CO., LIMITED: Q1 2024 Earnings Release (Projected)
2024-04-23 SINOCELLTECH GROUP LIMITED: Q1 2024 Earnings Release (Projected)
2024-04-23 SHANGHAI MEDICILON INC.: Q4 2023 Earnings Release
2024-04-24 04:05 pm VIKING THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24 REMEGEN CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 HITGEN INC.: Q4 2023 Earnings Release
More events

Past sector events for Imunon, Inc.

2024-04-17 BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-17 JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release
2024-04-12 SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release
2024-04-10 07:00 am NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-09 BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q4 2023 Earnings Release
2024-04-08 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release
2024-04-02 03:06 am TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release
2024-03-31 PEPTRON, INC.: Q4 2023 Earnings Release (Projected)
2024-03-31 BIONEER CORPORATION: Q4 2023 Earnings Release (Projected)
2024-03-29 08:30 am INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. IMNN Stock
  4. Calendar Imunon, Inc.